home.social

#ozempic — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #ozempic, aggregated by home.social.

  1. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  2. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  3. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  4. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  5. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  6. The Deadly Venom Behind Ozempic—and Why the Miracle Drug Should Have Never Worked

    When scientists first discovered the insulin secretion effects of gut hormone GLP-1 in the 1980s, it seemed like…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #diabetestreatment #Gilamonster #Health #insulinsecretion #Ozempic #Pharmaceuticals
    newsbeep.com/us/668167/

  7. The Deadly Venom Behind Ozempic—and Why the Miracle Drug Should Have Never Worked

    When scientists first discovered the insulin secretion effects of gut hormone GLP-1 in the 1980s, it seemed like…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #diabetestreatment #Gilamonster #Health #insulinsecretion #Ozempic #Pharmaceuticals
    newsbeep.com/us/668167/

  8. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  9. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  10. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  11. Generic semaglutide to hit Canadian pharmacies this week at lower cost

    Two generic versions of Ozempic and Wegovy are set to start arriving in Canadian pharmacies this week, which…
    #NewsBeep #News #Medication #Consumer #GLP-1 #Health #Ozempic #Semaglutide #UK #UnitedKingdom #Wegovy #weight-lossdrugs
    newsbeep.com/uk/602216/

  12. AI analysis of 400,000 Reddit posts identifies hidden side effects for weight-loss drugs like Ozempic and Wegovy

    Researchers used artificial intelligence to scan social media data, uncovering unreported symptoms associated with popular weight-loss drugs like Ozempic and Wegovy.

    newsnews.ai/article/ai-reddit-

  13. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  14. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  15. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  16. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  17. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  18. Generic semaglutide to hit Canadian pharmacies this week at a fraction of the cost of Ozempic

    TORONTO — Two generic versions of Ozempic are set to start arriving in Canadian pharmacies this week, which…
    #NewsBeep #News #Medication #Apotex #brand-name #CA #Canada #Canadianpharmacies #DrReddy #genericversions #Health #HealthCanada #Ozempic #patients #Pharmacies #ShoppersDrugMart #spokesperson
    newsbeep.com/ca/682949/

  19. Mounjaro vs Ozempic: head-to-head trial data suggests meaningful differences in weight loss outcomes between the two GLP-1 drugs. The clinical picture is worth reading carefully.

    isitcap.com/r/mounjaro-more-ef

    #GLP1 #Mounjaro #Ozempic #WeightLoss #Medicine #FactCheck

  20. Mounjaro vs Ozempic: head-to-head trial data suggests meaningful differences in weight loss outcomes between the two GLP-1 drugs. The clinical picture is worth reading carefully.

    isitcap.com/r/mounjaro-more-ef

    #GLP1 #Mounjaro #Ozempic #WeightLoss #Medicine #FactCheck

  21. Mounjaro vs Ozempic: head-to-head trial data suggests meaningful differences in weight loss outcomes between the two GLP-1 drugs. The clinical picture is worth reading carefully.

    isitcap.com/r/mounjaro-more-ef

    #GLP1 #Mounjaro #Ozempic #WeightLoss #Medicine #FactCheck

  22. Mounjaro vs Ozempic: head-to-head trial data suggests meaningful differences in weight loss outcomes between the two GLP-1 drugs. The clinical picture is worth reading carefully.

    isitcap.com/r/mounjaro-more-ef

    #GLP1 #Mounjaro #Ozempic #WeightLoss #Medicine #FactCheck

  23. GLP-1 drugs cut sick days, could save healthcare systems billions

    New Delhi: Ozempic and Wegovy, the drugs that have dominated global health headlines for their dramatic weight-loss effects,…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Anti-obesitydrugs #glp-1drugs #Health #Ozempic #Semaglutide #wegovy
    newsbeep.com/us/652330/

  24. GLP-1 drugs cut sick days, could save healthcare systems billions

    New Delhi: Ozempic and Wegovy, the drugs that have dominated global health headlines for their dramatic weight-loss effects,…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Anti-obesitydrugs #glp-1drugs #Health #Ozempic #Semaglutide #wegovy
    newsbeep.com/us/652330/

  25. Niente più iniezioni settimanali, penne in frigo ed effetti collaterali da accumulo: in Olanda è appena partito il primo trial al mondo di una terapia genica GLP-1.

    Una sola infusione direttamente nel pancreas, guidata da ecografia endoscopica, e il pancreas stesso impara a produrre GLP-1 ogni volta che mangi. 9 pazienti per cominciare (con molta cautela), 5 anni di follow-up, primi dati attesi entro fine 2026.

    futuroprossimo.it/2026/05/una-

    #futuroprossimo #GLP1 #terapiagenica #ozempic #salute

  26. Niente più iniezioni settimanali, penne in frigo ed effetti collaterali da accumulo: in Olanda è appena partito il primo trial al mondo di una terapia genica GLP-1.

    Una sola infusione direttamente nel pancreas, guidata da ecografia endoscopica, e il pancreas stesso impara a produrre GLP-1 ogni volta che mangi. 9 pazienti per cominciare (con molta cautela), 5 anni di follow-up, primi dati attesi entro fine 2026.

    futuroprossimo.it/2026/05/una-

    #futuroprossimo #GLP1 #terapiagenica #ozempic #salute

  27. Niente più iniezioni settimanali, penne in frigo ed effetti collaterali da accumulo: in Olanda è appena partito il primo trial al mondo di una terapia genica GLP-1.

    Una sola infusione direttamente nel pancreas, guidata da ecografia endoscopica, e il pancreas stesso impara a produrre GLP-1 ogni volta che mangi. 9 pazienti per cominciare (con molta cautela), 5 anni di follow-up, primi dati attesi entro fine 2026.

    futuroprossimo.it/2026/05/una-

    #futuroprossimo #GLP1 #terapiagenica #ozempic #salute